116 studies found for:    "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
21 Recruiting Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Conditions: Uveitis;   Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody;   Drug: placebo
22 Unknown  Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Infliximab plus methotrexate;   Drug: Combination of DMARDs;   Drug: Methotrexate alone
23 Active, not recruiting An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
24 Completed BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
25 Completed Active Juvenile Idiopathic Arthritis (JIA)Compassionate Use
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Adalimumab
26 Not yet recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
27 Active, not recruiting A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: CNTO 148 (Golimumab);   Biological: CNTO 148 (golimumab) or placebo
28 Completed Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
Condition: Systemic-Onset Juvenile Idiopathic Arthritis
Interventions: Drug: Anakinra;   Biological: Pneumo23
29 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
30 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
31 Unknown  The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
Conditions: Uveitis;   Arthritis, Juvenile Rheumatoid
Intervention: Drug: TNFR:Fc
32 Completed Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: meloxicam oral suspension;   Drug: naproxen oral suspension
33 Unknown  Jointstrong Intervention for Juvenile Arthritis
Condition: Juvenile Arthritis
Interventions: Behavioral: CD-ROM;   Behavioral: Wait-list Control Group
34 Unknown  Juvenile Rheumatoid Arthritis Research Registry
Condition: Juvenile Rheumatoid Arthritis
Intervention:
35 Recruiting Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: comparison of types of sleep disordered breathing
36 Completed Juvenile Rheumatoid Arthritis
Condition: Juvenile Chronic Arthritis
Interventions: Drug: Anakinra;   Drug: Placebo
37 Recruiting An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
38 Recruiting Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: etanercept
39 Completed Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Drug: Enbrel®
40 Completed TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
Conditions: Juvenile Rheumatoid Arthritis;   Uveitis
Intervention: Drug: Enbrel

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years